Small Molecule Inhibitors of Tumor-Promoted Angiogenesis, Including Protein Tyrosine Kinase Inhibitors
- 2 May 1999
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 82 (2-3) , 169-193
- https://doi.org/10.1016/s0163-7258(98)00053-9
Abstract
No abstract availableKeywords
This publication has 130 references indexed in Scilit:
- Potent anti-angiogenic action of AGM-1470: comparison to the fumagillin parentPublished by Elsevier ,2004
- The Proteasome Is Involved in AngiogenesisBiochemical and Biophysical Research Communications, 1998
- Inhibitory effect of the angiogenesis inhibitor TNP-470 on tumor growth and metastasis in nude mice bearing human hepatocellular carcinomaZeitschrift für Krebsforschung und Klinische Onkologie, 1997
- TNP-470 (AGM-1470): Mechanisms of action and early clinical developmentEuropean Journal Of Cancer, 1996
- Transgenic mouse models of tumour angiogenesis: the angiogenic switch, its molecular controls, and prospects for preclinical therapeutic modelsEuropean Journal Of Cancer, 1996
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisPublished by Elsevier ,1996
- Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppressionNature Medicine, 1995
- Thalidomide is an inhibitor of angiogenesis.Proceedings of the National Academy of Sciences, 1994
- Tumor Angiogenesis: Therapeutic ImplicationsNew England Journal of Medicine, 1971
- ISOLATION OF A TUMOR FACTOR RESPONSIBLE FOR ANGIOGENESISThe Journal of Experimental Medicine, 1971